|
1
|
Diong S, Clowry J, Wynne B. General dermatology and dermatology in primary healthcare. Clin Exp Dermatol 2024; 49:418-419. [PMID: 38123491 DOI: 10.1093/ced/llad454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 12/12/2023] [Accepted: 12/18/2023] [Indexed: 12/23/2023]
Abstract
Heparin-induced bullous haemorrhagic dermatosis is an uncommon cutaneous adverse reaction to heparin, thought to be under-reported owing to its relatively asymptomatic presentation and favourable prognosis. This vesiculobullous condition is largely self-limiting and tends to resolve spontaneously despite continued anticoagulant therapy. Correct identification can reassure clinicians and patients alike.
Collapse
Affiliation(s)
- Sophie Diong
- Dermatology Department, St James's Hospital Dublin Ireland, Dublin, Ireland
| | - Julianne Clowry
- Dermatology Department, St James's Hospital Dublin Ireland, Dublin, Ireland
| | - Bairbre Wynne
- Dermatology Department, St James's Hospital Dublin Ireland, Dublin, Ireland
| |
Collapse
|
|
2
|
Hamdi D, Korbi M, Sahnoun D, Boussaada MM, El Mabrouk RS, Belhadjali H, Chaabane A, Zili J. Heparin-induced bullous hemorrhagic dermatosis. Therapie 2022; 77:745-747. [PMID: 35606191 PMCID: PMC9121283 DOI: 10.1016/j.therap.2022.02.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Revised: 10/27/2021] [Accepted: 02/24/2022] [Indexed: 01/13/2023]
Affiliation(s)
- Douja Hamdi
- Dermatology Department, Fattouma Bourguiba University Hospital, University of Monastir, 5000 Monastir, Tunisia
| | - Mouna Korbi
- Dermatology Department, Fattouma Bourguiba University Hospital, University of Monastir, 5000 Monastir, Tunisia,Research laboratory LR20SP03A, University of Monastir, 5000 Monastir, Tunisia,Corresponding author
| | - Dhouha Sahnoun
- Pharmacology Department, Fattouma Bourguiba University Hospital, University of Monastir, 5000 Monastir, Tunisia
| | - Mohamed Mehdi Boussaada
- Cardiology Department, Fattouma Bourguiba University Hospital, University of Monastir, 5000 Monastir, Tunisia
| | - Randa Said El Mabrouk
- Dermatology Department, Fattouma Bourguiba University Hospital, University of Monastir, 5000 Monastir, Tunisia
| | - Hichem Belhadjali
- Dermatology Department, Fattouma Bourguiba University Hospital, University of Monastir, 5000 Monastir, Tunisia,Research laboratory LR20SP03A, University of Monastir, 5000 Monastir, Tunisia
| | - Amel Chaabane
- Pharmacology Department, Fattouma Bourguiba University Hospital, University of Monastir, 5000 Monastir, Tunisia
| | - Jameleddine Zili
- Dermatology Department, Fattouma Bourguiba University Hospital, University of Monastir, 5000 Monastir, Tunisia,Research laboratory LR20SP03A, University of Monastir, 5000 Monastir, Tunisia
| |
Collapse
|